Who we are and what we do
GSK.ca
Our news
Medicago and GSK announce positive interim Phase 2 results for adjuvanted COVID-19 vaccine candidate
GSK’s ZEJULA is recommended for reimbursement by CADTH and INESSS for advanced ovarian cancer following response to first-line platinum-based chemotherapy
Medicago and GSK start Phase 3 trial of adjuvanted COVID-19 vaccine candidate
Transparency reporting
At GSK, we’re committed to building transparency as we believe it enhances trust for patients and our healthcare system. Since 2017, GSK has voluntarily disclosed in aggregate payments to Healthcare Professionals (HCPs) and payments to Healthcare Organizations (HCOs). Starting this year, we are expanding the reporting to include payments to individual HCPs. You can view our transparency reporting here.
Learn more about transparency reporting
Explore our products
We make a wide range of prescription medicines, prescribed vaccines and consumer healthcare products.
Working at GSK
Looking for a new career? Find out about working at GSK and how to apply for a job.
